RxDoctor Payments Data

Henry Dupre, MD

Family Medicine · Ville Platte, LANPI 1811935935

Payments from drug & device makers

$406in general payments, 2019–2025

Across 22 payments — averaging $18.44 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$83
  • Pfizer$65
  • Cardiovascular Systems Inc.$61
  • Lilly USA, LLC$32
  • Supernus Pharmaceuticals, Inc.$30
  • Novo Nordisk$28
  • plus $108 from 7 others

What the payments were for

  • Food & beverage$406100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$406 in reported general payments places this provider in the 40th percentile of 1,469 family medicine providers in Louisiana.

See all family medicine providers in Louisiana

Medicare billing

Part B allowed, 2024
$704
Medicare patients
19
Services billed
31

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
TrulicityDulaglutide80$84,679
OzempicSemaglutide46$43,189
MounjaroTirzepatide28$34,477
Trelegy ElliptaFluticasone/Umeclidin/Vilanter42$27,779
JanuviaSitagliptin Phosphate49$22,757
EliquisApixaban38$21,961
FarxigaDapagliflozin Propanediol23$15,489
JardianceEmpagliflozin14$12,813
XareltoRivaroxaban21$11,492
TrintellixVortioxetine Hydrobromide18$8,433
LinzessLinaclotide12$6,248
MyrbetriqMirabegron13$5,696
Spiriva HandihalerTiotropium Bromide11$5,669
Icosapent Ethyl13$5,310
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen270$3,695

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Lilly USA, LLCTrulicity, Mounjaro$32$119,156108 claims
Novo NordiskOzempic$28$43,18946 claims
PfizerEliquis$65$21,96138 claims
AstraZenecaFarxiga$19$15,48923 claims
Takeda Pharmaceuticals U.S.A., Inc.Trintellix$11$8,43318 claims
AbbVieLinzess$83$6,24812 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 40th percentile of 1,469 family medicine providers in Louisiana.

Other family medicine in Ville Platte

See the full list for Louisiana

Where these figures come from

Is this you, or does something look wrong? →